Literature DB >> 22411664

Extraocular muscles in patients with infantile nystagmus: adaptations at the effector level.

Kathleen T Berg1, David G Hunter, Erick D Bothun, Rosalia Antunes-Foschini, Linda K McLoon.   

Abstract

OBJECTIVE: To test the hypothesis that the extraocular muscles (EOMs) of patients with infantile nystagmus have muscular and innervational adaptations that may have a role in the involuntary oscillations of the eyes.
METHODS: Specimens of EOMs from 10 patients with infantile nystagmus and postmortem specimens from 10 control subjects were prepared for histologic examination. The following variables were quantified: mean myofiber cross-sectional area, myofiber central nucleation, myelinated nerve density, nerve fiber density, and neuromuscular junction density.
RESULTS: In contrast to control EOMs, infantile nystagmus EOMs had significantly more centrally nucleated myofibers, consistent with cycles of degeneration and regeneration. The EOMs of patients with nystagmus also had a greater degree of heterogeneity in myofiber size than did those of controls, with no difference in mean myofiber cross-sectional area. Mean myelinated nerve density, nerve fiber density, and neuromuscular junction density were also significantly decreased in infantile nystagmus EOMs.
CONCLUSIONS: The EOMs of patients with infantile nystagmus displayed a distinct hypoinnervated phenotype. This represents the first quantification of changes in central nucleation and myofiber size heterogeneity, as well as decreased myelinated nerve, nerve fiber, and neuromuscular junction density. These results suggest that deficits in motor innervation are a potential basis for the primary loss of motor control. CLINICAL RELEVANCE: Improved understanding of the etiology of nystagmus may direct future diagnostic and treatment strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22411664      PMCID: PMC3759680          DOI: 10.1001/archophthalmol.2011.381

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Pre- and post-rigor fixation of muscle.

Authors:  G Goldspink; S Gelder; L Clapison; P Overfield
Journal:  J Anat       Date:  1973-01       Impact factor: 2.610

Review 2.  Nystagmus.

Authors:  I Gottlob
Journal:  Curr Opin Ophthalmol       Date:  2000-10       Impact factor: 3.761

3.  Activated satellite cells in extraocular muscles of normal adult monkeys and humans.

Authors:  Linda K McLoon; Jonathan Wirtschafter
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

4.  Continuous myonuclear addition to single extraocular myofibers in uninjured adult rabbits.

Authors:  Linda K McLoon; Jonathan D Wirtschafter
Journal:  Muscle Nerve       Date:  2002-03       Impact factor: 3.217

5.  Motor and sensory characteristics of infantile nystagmus.

Authors:  R V Abadi; A Bjerre
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  A novel frameshift mutation in FRMD7 causing X-linked idiopathic congenital nystagmus.

Authors:  Xiang He; Feng Gu; Ze Wang; Chong Wang; Yi Tong; Yujing Wang; Juhua Yang; Wei Liu; Meng Zhang; Xu Ma
Journal:  Genet Test       Date:  2008-12

7.  Congenital nystagmus: hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model.

Authors:  Jonathan B Jacobs; Louis F Dell'Osso
Journal:  J Vis       Date:  2004-07-27       Impact factor: 2.240

8.  Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis.

Authors:  Linda K McLoon; Jocelyn Rowe; Jonathan Wirtschafter; Kathleen M McCormick
Journal:  Muscle Nerve       Date:  2004-05       Impact factor: 3.217

9.  The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development.

Authors:  Joanne Betts-Henderson; Stefano Bartesaghi; Moira Crosier; Susan Lindsay; Hai-Lan Chen; Paolo Salomoni; Irene Gottlob; Pierluigi Nicotera
Journal:  Hum Mol Genet       Date:  2009-11-05       Impact factor: 6.150

10.  Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2.

Authors:  Valerio Pisani; Maria Beatrice Panico; Chiara Terracciano; Emanuela Bonifazi; Giovanni Meola; Giuseppe Novelli; Giorgio Bernardi; Corrado Angelini; Roberto Massa
Journal:  Muscle Nerve       Date:  2008-11       Impact factor: 3.217

View more
  6 in total

1.  Strabismus and the Oculomotor System: Insights from Macaque Models.

Authors:  Vallabh E Das
Journal:  Annu Rev Vis Sci       Date:  2016-07-18       Impact factor: 6.422

2.  Severity of infantile nystagmus syndrome-like ocular motor phenotype is linked to the extent of the underlying optic nerve projection defect in zebrafish belladonna mutant.

Authors:  Sabina P Huber-Reggi; Chien-Cheng Chen; Lea Grimm; Dominik Straumann; Stephan C F Neuhauss; Melody Ying-Yu Huang
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

3.  Spontaneous Nystagmus in the Dark in an Infantile Nystagmus Patient May Represent Negative Optokinetic Afternystagmus.

Authors:  Ting-Feng Lin; Christina Gerth-Kahlert; James V M Hanson; Dominik Straumann; Melody Ying-Yu Huang
Journal:  Front Neurol       Date:  2018-03-14       Impact factor: 4.003

4.  Impaired Extraocular Muscle Innervation Is Present Before Eye Opening in a Mouse Model of Infantile Nystagmus Syndrome.

Authors:  Sampath Kumar Vemula; Seoyoung A Kim; Tapiwa Muvavarirwa; Jessica L Bell; Mary C Whitman
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

Review 5.  Nystagmus in pediatric patients: interventions and patient-focused perspectives.

Authors:  Kimberly Penix; Mark W Swanson; Dawn K DeCarlo
Journal:  Clin Ophthalmol       Date:  2015-08-21

6.  Abnormally Small Neuromuscular Junctions in the Extraocular Muscles From Subjects With Idiopathic Nystagmus and Nystagmus Associated With Albinism.

Authors:  Linda K McLoon; Christy L Willoughby; Jill S Anderson; Erick D Bothun; David Stager; Joost Felius; Helena Lee; Irene Gottlob
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.